Gil Benard

5.3k total citations
156 papers, 3.1k citations indexed

About

Gil Benard is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Gil Benard has authored 156 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Epidemiology, 97 papers in Infectious Diseases and 31 papers in Immunology. Recurrent topics in Gil Benard's work include Fungal Infections and Studies (88 papers), Antifungal resistance and susceptibility (68 papers) and Nail Diseases and Treatments (31 papers). Gil Benard is often cited by papers focused on Fungal Infections and Studies (88 papers), Antifungal resistance and susceptibility (68 papers) and Nail Diseases and Treatments (31 papers). Gil Benard collaborates with scholars based in Brazil, Paraguay and United States. Gil Benard's co-authors include Alberto J.S. Duarte, Maria José Soares Mendes‐Giannini, Gilda Maria Bárbaro Del Negro, João Nóbrega de Almeida, Carla Cristina Romano, Alberto José da Silva Duarte, Christiane Pienna Soares, Maria Ângela Bianconcini Trindade, Maria Aparecida Shikanai‐Yasuda and Maria Glória Teixeira Sousa and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Gil Benard

147 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gil Benard Brazil 31 2.2k 1.8k 502 392 274 156 3.1k
Sílvio Alencar Marques Brazil 29 1.9k 0.9× 1.2k 0.7× 317 0.6× 406 1.0× 220 0.8× 144 2.6k
Malcolm Finkelman United States 33 1.9k 0.9× 2.2k 1.2× 342 0.7× 214 0.5× 803 2.9× 88 3.6k
Jorge Ocampo‐Candiani Mexico 28 920 0.4× 708 0.4× 279 0.6× 480 1.2× 318 1.2× 239 3.0k
Louis Yi Ann Chai Singapore 29 883 0.4× 1.5k 0.8× 465 0.9× 100 0.3× 516 1.9× 67 2.9k
Takayoshi Tashiro Japan 32 1.5k 0.7× 1.5k 0.8× 216 0.4× 146 0.4× 439 1.6× 141 2.7k
Roberto Arenas Mexico 30 2.0k 0.9× 956 0.5× 161 0.3× 909 2.3× 186 0.7× 298 3.0k
Christopher H. Mody Canada 40 2.2k 1.0× 1.7k 0.9× 1.4k 2.8× 103 0.3× 775 2.8× 116 4.6k
Silvia Moretti Italy 35 1.3k 0.6× 1.7k 0.9× 1.5k 3.1× 104 0.3× 897 3.3× 57 3.8k
Cornelia Speth Austria 34 983 0.4× 1.3k 0.7× 972 1.9× 121 0.3× 542 2.0× 106 3.0k
Jorge Pedrosa Portugal 34 1.8k 0.8× 1.6k 0.8× 949 1.9× 41 0.1× 450 1.6× 73 3.4k

Countries citing papers authored by Gil Benard

Since Specialization
Citations

This map shows the geographic impact of Gil Benard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Benard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Benard more than expected).

Fields of papers citing papers by Gil Benard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gil Benard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Benard. The network helps show where Gil Benard may publish in the future.

Co-authorship network of co-authors of Gil Benard

This figure shows the co-authorship network connecting the top 25 collaborators of Gil Benard. A scholar is included among the top collaborators of Gil Benard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gil Benard. Gil Benard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Veasey, John Verrinder, et al.. (2025). First case of Trichophyton indotineae in Brazil: clinical and mycological criteria and genetic identification of terbinafine resistance. Anais Brasileiros de Dermatologia. 100(3). 557–560. 3 indexed citations
3.
Rossi, Flávia, Thaís Guimarães, Rinaldo Focaccia Siciliano, et al.. (2025). Nine-Year Surveillance of Candida parapsilosis Candidemia in a Cardiothoracic ICU: Insights into Mortality and Resistance. Journal of Fungi. 11(10). 692–692.
4.
Negro, Gilda Maria Bárbaro Del, et al.. (2025). First documentation of Aspergillus welwitschiae in COVID-19-associated pulmonary aspergillosis in the Americas. Revista do Instituto de Medicina Tropical de São Paulo. 67. e8–e8. 1 indexed citations
5.
Gimenes, Viviane Mazo Fávero, et al.. (2023). Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis – CAPA. The Brazilian Journal of Infectious Diseases. 27(4). 102793–102793. 3 indexed citations
6.
Freitas, Vera Lúcia Teixeira de, Marcello Mihailenko Chaves Magri, Flávia Rossi, et al.. (2023). Performance of a Real-Time PCR Assay for the Detection of Five Candida Species in Blood Samples from ICU Patients at Risk of Candidemia. Journal of Fungi. 9(6). 635–635. 3 indexed citations
7.
Carvalho‐Pinto, Regina Maria, et al.. (2023). Human peripheral blood age‐associated ( CD11c+Tbet+ ) B cells: No association with age. Cytometry Part A. 103(8). 619–623. 1 indexed citations
8.
Pereira‐Chioccola, Vera Lúcia, et al.. (2022). Performance of a Real Time PCR for Pneumocystis jirovecii Identification in Induced Sputum of AIDS Patients: Differentiation between Pneumonia and Colonization. Journal of Fungi. 8(3). 222–222. 7 indexed citations
9.
Thomaz, Danilo Yamamoto, Gilda Maria Bárbaro Del Negro, Carlos Henrique Camargo, et al.. (2022). A Brazilian Inter-Hospital Candidemia Outbreak Caused by Fluconazole-Resistant Candida parapsilosis in the COVID-19 Era. Journal of Fungi. 8(2). 100–100. 41 indexed citations
10.
Gozzi-Silva, Sarah Cristina, Gil Benard, Ricardo Wesley Alberca, et al.. (2021). SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy: A Case Report. Tropical Medicine and Infectious Disease. 6(1). 22–22. 10 indexed citations
11.
Thomaz, Danilo Yamamoto, Márcia de Souza Carvalho Melhem, João Nóbrega de Almeida, Gil Benard, & Gilda Maria Bárbaro Del Negro. (2020). Lack of efficacy of echinocandins against high metabolic activity biofilms of Candida parapsilosis clinical isolates. Brazilian Journal of Microbiology. 51(3). 1129–1133. 5 indexed citations
12.
Litvinov, Nadia, Jaques Sztajnbok, Danilo Yamamoto Thomaz, et al.. (2018). Lomentospora prolificans fungemia in hematopoietic stem cell transplant patients: First report in South America and literature review. Transplant Infectious Disease. 20(4). e12908–e12908. 11 indexed citations
13.
Taborda, Carlos P., Renata Buccheri, Gil Benard, et al.. (2018). Paracoccidioides spp. and Histoplasma capsulatum: Current and New Perspectives for Diagnosis and Treatment. Current Topics in Medicinal Chemistry. 18(15). 1333–1348. 13 indexed citations
14.
Costa, André Nathan, Gil Benard, André Luís Pereira de Albuquerque, et al.. (2013). The lung in paracoccidioidomycosis: new insights into old problems. Clinics. 68(4). 441–448. 28 indexed citations
15.
Benard, Gil, et al.. (2010). Fatal acute respiratory distress syndrome in a patient with paracoccidioidomycosis: first case report. Medical Mycology. 48(3). 542–545. 6 indexed citations
16.
18.
Romano, Carla Cristina, Maria José Soares Mendes‐Giannini, Alberto J.S. Duarte, & Gil Benard. (2002). IL-12 AND NEUTRALIZATION OF ENDOGENOUS IL-10 REVERT THE IN VITRO ANTIGEN-SPECIFIC CELLULAR IMMUNOSUPPRESSION OF PARACOCCIDIOIDOMYCOSIS PATIENTS. Cytokine. 18(3). 149–157. 43 indexed citations
19.
Biselli, Paolo, et al.. (2001). IgE antibody response to the main antigenic component ofParacoccidioides brasiliensisin patients with paracoccidioidomycosis. Medical Mycology. 39(6). 475–478. 9 indexed citations
20.
Benard, Gil, et al.. (1994). Severe acute paracoccidioidomycosis in children. PubMed. 13(6). 510–515. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026